These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31494765)

  • 1. ARID1A, Prostaglandin E2, and Its Receptor as Possible Predictors of Malignant Transformation of the Endometrium in Endometriosis.
    Dyatlova AS; Lin'kova NS; Polyakova VO; Samoshkin NG; Kvetnoi IM
    Bull Exp Biol Med; 2019 Aug; 167(4):504-507. PubMed ID: 31494765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of ARID1A is sufficient to initiate neoplastic transformation along with epigenetic reprogramming in non-tumorigenic endometriotic cells.
    Lakshminarasimhan R; Andreu-Vieyra C; Lawrenson K; Duymich CE; Gayther SA; Liang G; Jones PA
    Cancer Lett; 2017 Aug; 401():11-19. PubMed ID: 28483516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (Partial) Loss of BAF250a (ARID1A) in rectovaginal deep-infiltrating endometriosis, endometriomas and involved pelvic sentinel lymph nodes.
    Borrelli GM; Abrão MS; Taube ET; Darb-Esfahani S; Köhler C; Chiantera V; Mechsner S
    Mol Hum Reprod; 2016 May; 22(5):329-37. PubMed ID: 26832958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ARID1A and PGR proteins interact in the endometrium and reveal a positive correlation in endometriosis.
    Kim HI; Kim TH; Yoo JY; Young SL; Lessey BA; Ku BJ; Jeong JW
    Biochem Biophys Res Commun; 2021 Apr; 550():151-157. PubMed ID: 33706098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of ARID1A/BAF250a-expression in endometriosis: a biomarker for risk of carcinogenic transformation?
    Samartzis EP; Samartzis N; Noske A; Fedier A; Caduff R; Dedes KJ; Fink D; Imesch P
    Mod Pathol; 2012 Jun; 25(6):885-92. PubMed ID: 22301703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stretch magnitude- and frequency-dependent cyclooxygenase 2 and prostaglandin E2 up-regulation in human endometrial stromal cells: possible implications in endometriosis.
    Li X; Gong X; Zhu L; Leng J; Fan Q; Sun D; Lang J; Fan Y
    Exp Biol Med (Maywood); 2012 Nov; 237(11):1350-8. PubMed ID: 23239446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ARID1A protein expression is retained in ovarian endometriosis with ARID1A loss-of-function mutations: implication for the two-hit hypothesis.
    Yachida N; Yoshihara K; Suda K; Nakaoka H; Ueda H; Sugino K; Yamaguchi M; Mori Y; Yamawaki K; Tamura R; Ishiguro T; Isobe M; Motoyama T; Inoue I; Enomoto T
    Sci Rep; 2020 Aug; 10(1):14260. PubMed ID: 32868822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of Arid1a in the endometrium is associated with endometrioid tumorigenesis through transcriptional reprogramming.
    Suryo Rahmanto Y; Shen W; Shi X; Chen X; Yu Y; Yu ZC; Miyamoto T; Lee MH; Singh V; Asaka R; Shimberg G; Vitolo MI; Martin SS; Wirtz D; Drapkin R; Xuan J; Wang TL; Shih IM
    Nat Commun; 2020 Jun; 11(1):2717. PubMed ID: 32483112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ARID1A Mutations Promote P300-Dependent Endometrial Invasion through Super-Enhancer Hyperacetylation.
    Wilson MR; Reske JJ; Holladay J; Neupane S; Ngo J; Cuthrell N; Wegener M; Rhodes M; Adams M; Sheridan R; Hostetter G; Alotaibi FT; Yong PJ; Anglesio MS; Lessey BA; Leach RE; Teixeira JM; Missmer SA; Fazleabas AT; Chandler RL
    Cell Rep; 2020 Nov; 33(6):108366. PubMed ID: 33176148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and significance of ARID1A mRNA in endometriosis- associated ovarian cancer.
    Wang Q; Wang L; L Y; Ding X; Liu A
    J BUON; 2017; 22(5):1314-1321. PubMed ID: 29135119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parthenolide reduces cell proliferation and prostaglandin E2 [corrected] in human endometriotic stromal cells and inhibits development of endometriosis in the murine model.
    Takai E; Taniguchi F; Nakamura K; Uegaki T; Iwabe T; Harada T
    Fertil Steril; 2013 Oct; 100(4):1170-8. PubMed ID: 23876538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathology and ARID1A Expression in Endometriosis- Associated Ovarian Carcinoma (EAOC) Carcinogenesis Model with Endometrial Autoimplantation and DMBA Induction.
    Wuyung PE; Rahadiati FB; Tjahjadi H; Salinah S; Kusmardi K; Kodariah R; Wiweko B
    Asian Pac J Cancer Prev; 2021 Feb; 22(2):553-558. PubMed ID: 33639673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ARID1A pathway in ovarian clear cell and endometrioid carcinoma, contiguous endometriosis, and benign endometriosis.
    Chene G; Ouellet V; Rahimi K; Barres V; Provencher D; Mes-Masson AM
    Int J Gynaecol Obstet; 2015 Jul; 130(1):27-30. PubMed ID: 25912412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial epithelial ARID1A is critical for uterine gland function in early pregnancy establishment.
    Marquardt RM; Kim TH; Yoo JY; Teasley HE; Fazleabas AT; Young SL; Lessey BA; Arora R; Jeong JW
    FASEB J; 2021 Feb; 35(2):e21209. PubMed ID: 33222288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AP-1 Subunit JUNB Promotes Invasive Phenotypes in Endometriosis.
    Wilson MR; Reske JJ; Chandler RL
    Reprod Sci; 2022 Nov; 29(11):3266-3277. PubMed ID: 35616875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer.
    Er TK; Su YF; Wu CC; Chen CC; Wang J; Hsieh TH; Herreros-Villanueva M; Chen WT; Chen YT; Liu TC; Chen HS; Tsai EM
    J Mol Med (Berl); 2016 Jul; 94(7):835-47. PubMed ID: 26920370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epigenetic inactivation of SPOCK2 in the malignant transformation of ovarian endometriosis].
    Ren F; Wang DB; Li T
    Zhonghua Fu Chan Ke Za Zhi; 2011 Nov; 46(11):822-5. PubMed ID: 22333230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ARID1A Is Essential for Endometrial Function during Early Pregnancy.
    Kim TH; Yoo JY; Wang Z; Lydon JP; Khatri S; Hawkins SM; Leach RE; Fazleabas AT; Young SL; Lessey BA; Ku BJ; Jeong JW
    PLoS Genet; 2015 Sep; 11(9):e1005537. PubMed ID: 26378916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemistry expression of targeted therapies biomarkers in ovarian clear cell and endometrioid carcinomas (type I) and endometriosis.
    Barreta A; Sarian LO; Ferracini AC; Costa LBE; Mazzola PG; de Angelo Andrade L; Derchain S
    Hum Pathol; 2019 Mar; 85():72-81. PubMed ID: 30447298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deoxyribonucleic acid methyltransferases and methyl-CpG-binding domain proteins in human endometrium and endometriosis.
    van Kaam KJ; Delvoux B; Romano A; D'Hooghe T; Dunselman GA; Groothuis PG
    Fertil Steril; 2011 Mar; 95(4):1421-7. PubMed ID: 21316665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.